Fifty years since the discovery of ibuprofen
- K. D. Rainsford
- … show all 1 hide
Related Content
Supplementary Material (0)
References (36)
- Adams SS (1987) The discovery of Brufen. Chem Br 23:1193–1195
- Adams SS (1988) Non-steroidal anti-inflammatory drugs, plasma half-lives, and adverse reactions. Lancet 2:1204–1205
- Adams SS, Cobb R (1967) Non-steroidal antiinflammatory drugs. In: Ellis GP, West GB (eds) Progress in medicinal chemistry 5. Butterworths, London, pp 59–133 CrossRef
- Antman EM, Bennett JS, Daugherty A, Furberg C, Roberts H, Taubert KA, American Heart Association (2007) Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association. Circulation 115:1634–1642 CrossRef
- Beaver WT (2003) Review of the analgesic efficacy of ibuprofen. Int J Clin Pract Suppl 135:13–17
- Blain H, Boileau C, Lapicque F, Nédélec E, Loeuille D, Guillaume C, Gaucher A, Jeandel C, Netter P, Jouzeau JY (2002) Limitation of the in vitro whole blood assay for predicting the COX selectivity of NSAIDs in clinical use. Br J Clin Pharmacol 53:255–265
- Brasky TM, Velicer CM, Kristal AR, Peters U, Potter JD, White E (2010) Nonsteroidal anti-inflammatory drugs and prostate cancer risk in the VITamins And Lifestyle (VITAL) cohort. Cancer Epidemiol Biomarkers Prev 19:3185–3188 CrossRef
- Brasky TM, Bonner MR, Moysich KB, Ambrosone CB, Nie J, Tao MH, Edge SB, Kallakury BV, Marian C, Goerlitz DS, Trevisan M, Shields PG, Freudenheim JL (2011) Non-steroidal anti-inflammatory drugs (NSAIDs) and breast cancer risk: differences by molecular subtype. Cancer Causes Control 22:965–975 CrossRef
- Brune K (2007) Persistence of NSAIDs at effect sites and rapid disappearance from side-effect compartments contributes to tolerability. Curr Med Res Opin 23:2985–2995 CrossRef
- Cryer B, Berlin RG, Cooper SA, Hsu C, Wason S (2005) Double-blind, randomized, parallel, placebo-controlled study of ibuprofen effects on thromboxane B2 concentrations in aspirin-treated healthy adult volunteers. Clin Ther 27:185–191 CrossRef
- Greenspan EJ, Madigan JP, Boardman LA, Rosenberg DW (2011) Ibuprofen inhibits activation of nuclear {beta}-catenin in human colon adenomas and induces the phosphorylation of GSK-3{beta}. Cancer Prev Res 4:161–171 CrossRef
- Harris RE (ed) (2002) COX-2 blockade in cancer prevention and therapy. Humana Press, NJ, Totawa
- Higton F (1999) The pharmaceutics of ibuprofen. In: Rainsford KD (ed) Ibuprofen. A critical bibliographic review. Taylor & Francis, London, pp 55–86
- Hirohata M, Ono K, Morinaga A, Yamada M (2008) Non-steroidal anti-inflammatory drugs have potent anti-fibrillogenic and fibril-destabilizing effects for alpha-synuclein fibrils in vitro. Neuropharmacology 54:620–627 CrossRef
- Kean WF, Rainsford KD, Kean IRL (2008) Management of chronic musculoskeletal pain in the elderly: opinions on oral medication use. Inflammopharmacology 16:53–75 CrossRef
- Kotilinek LA, Westerman MA, Wang Q, Panizzon K, Lim GP, Simonyi A, Lesne S, Falinska A, Younkin LH, Younkin SG, Rowan M, Cleary J, Wallis RA, Sun GY, Cole G, Frautschy S, Anwyl R, Ashe KH (2008) Cyclooxygenase-2 inhibition improves amyloid-beta-mediated suppression of memory and synaptic plasticity. Brain 131:651–664
- Mahmud SM, Franco EL, Turner D, Platt RW, Beck P, Skarsgard D, Tonita J, Sharpe C, Aprikian AG (2011). Use of non-steroidal anti-inflammatory drugs and prostate cancer risk: a population-based nested case–control study. PLoS One 6(1):e16412
- Massey T, Derry S, Moore RA, McQuay HJ (2010) Topical NSAIDs for acute pain in adults. Cochr Database Syst Rev (6):CD007402
- Nicholson JS (1982) Ibuprofen. In: Bindra JS, Lednicer D (eds) Chronicles of drug discovery, Chapter 7, vol 1. Wiley, New York, pp 149–171
- Psaty BM, Furberg CD (2005) COX-2 inhibitors—lessons in drug safety. N Engl J Med 352:1133–1135 CrossRef
- Purcell H (2007) Ibuprofen and cardiovascular safety: where do we stand? J R Soc Med 100(Suppl 48):7–10
- Rainsford KD (1987) Introduction and historical aspects of the side effects of anti-inflammatory analgesic drugs. In: Rainsford KD, Velo GP (eds) Side effects of anti-inflammatory analgesic drugs, vol 1. MTP Press, Lancaster, pp 3–26
- Rainsford KD (1999) History and development of ibuprofen. In: Rainsford KD (ed) Ibuprofen. A critical bibliographic review, Chapter 1. Taylor & Francis, London, pp 3–24
- Rainsford KD (2003) Discovery, mechanisms of action and safety of ibuprofen. Intl J Clin Pract Suppl (135):3–8
- Rainsford KD (2009) Ibuprofen: pharmacology, efficacy and safety. Inflammopharmacology 17:275–342 CrossRef
- Rainsford KD (2012) Ibuprofen. Pharmacology, therapeutics and side effects. Springer press, Basel and Heidelberg (in press)
- Rainsford KD, Kean WF, Ehrlich GE (2008) Triad (GI, CV, Hepatic) composite toxicity ratings for use in assessing the overall safety of NSAIDs. Intern Med J, 38(Suppl. 2):A32 (Abstract No. ARP71)
- Rostrom A, Dube C, Lewin G (2007) Use of aspirin and NSAIDs to prevent colorectal cancer (Internet). Agency for Healthcare Research and Quality (US), Rockville. (Available from http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=es45)
- Strand V (2007) Are COX-2 inhibitors preferable to non-selective non-steroidal anti-inflammatory drugs in patients with risk of cardiovascular events taking low-dose aspirin? Lancet 370:2138–2151 CrossRef
- Sullivan JE, Farrar HC (2011) Section on clinical pharmacology and therapeutics; committee on drugs, fever and antipyretic use in children. Pediatrics 127:580–587 CrossRef
- Topol EJ (2005) Arthritis medicines and cardiovascular events–“house of coxibs”. J Am Med Assn 293(3):366–368 CrossRef
- Townsend KP, Praticò D (2005) Novel therapeutic opportunities for Alzheimer’s disease: focus on nonsteroidal anti-inflammatory drugs. FASEB J 19:1592–1601 CrossRef
- Trelle S, Reichenbach S, Wandel S, Hildebrand P, Tschannen B, Villiger PM, Egger M, Jüni P (2011) Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis. Br Med J 342:7086 CrossRef
- Volans G, Monaghan J, Colbridge M (2003) Ibuprofen overdose. Int J Clin Pract Suppl (135):54–60
- Woodman TJ, Wood PJ, Thompson AS, Hutchings TJ, Steel GR, Jiao P, Threadgill MD, Lloyd MD (2011) Chiral inversion of 2-arylpropionyl–CoA esters by human α-methylacyl-CoA racemase 1A (P504S)—a potential mechanism for the anti-cancer effects of ibuprofen. Chem Commun 47:7332–7334 CrossRef
- Wynne S, Djakiew D (2010) NSAID inhibition of prostate cancer cell migration is mediated by Nag-1 Induction via the p38 MAPK-p75(NTR) pathway. Mol Cancer Res 8:1656–1664 CrossRef
About this Article
- Title
- Fifty years since the discovery of ibuprofen
- Journal
-
Inflammopharmacology
Volume 19, Issue 6 , pp 293-297 - Cover Date
- 2011-12-01
- DOI
- 10.1007/s10787-011-0103-7
- Print ISSN
- 0925-4692
- Online ISSN
- 1568-5608
- Publisher
- SP Birkhäuser Verlag Basel
- Additional Links
- Topics
- Industry Sectors
- Authors
-
-
K. D. Rainsford
(1)
-
K. D. Rainsford
- Author Affiliations
-
- 1. Emeritus Professor, Biomedical Research Centre, Sheffield Hallam University, Howard Street, Sheffield, S11WB, England, UK